Andersson T, Hassan-Alin M, Hasselgren G, R hss K, Weidolf L. Pharmacokinetic studies with esomeprazole , the (S)-isomer of omeprazole. Clin Pharmacokinet 2001; 40:411-426.

Andersson Т., Bredberg E., Sunzel M. etal. Pharmacokinetics and effect on pentagastrin stimulated peak acid output of omeprazole and its 2 optical isomers, S-omeprazole/esomeprazole and R-omeprazole//Gastroenterol. - 2000. - Vol. 118.-A1210

Bardou M, Toubouti Y, Benhaberou-Brun D, Rahme E, Barkun AN. Meta-analysis: proton-pump inhibition in high-risk patients with acute peptic ulcer bleeding. Aliment Pharmacol Ther 2005;21:677-686.

Barkun A, et al. Scand J Gastroenterol 2008; 43 (Suppl244):P11.

Barkun A., Bardou M., Marshall J._Consensus Recommendations for Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding, 2003.

Castell D.O., Kahrilas P.J., Richter J.E. etal. Esome-prazole is more effective than lansoprazole for treating daily and nocturnal heartburn (HB) in GERD patients with erosive esophagitis (EE) //

J. Gastroenterol. Hepatol. - 2002. - Vol. 17 (Suppl.).-A232.

Church N., Palmer K. Ulcers and nonvariceal bleeding. Endoscopy, 2003;35:22-6.

Creutzfeldt W. Chiral switch a successful way for developing drug: Example of esomeprazole // Z. Gastroenterol. - 2000. - Vol. 38. - P. 893897.

Daneshmend TK, Hawkey CJ, Langmann MJS, Logan RFA, Long RG, Walt RP. Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. BMJ 1992;304:143-147.

GentaR.M., Magner D.J., D'Amico D. Safety of longterm treatment with a new PPI esomeprazole in GERD patients // Gastroenterol. - 2000. - Vol. 118. - A16.

Gerson L.B., Robbins A.S., Garber A. et al. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease//Am. J. Gastroenterol. - 2000. - Vol. 95, №2. - P. 395-407.

Green FW Jr, Kaplan MM, Curtis LE, Levine PH. Effect of acid and pepsin on blood coagulation and platelet aggregation: a possible contributor to prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 1978;74:38-43.

Hassan-Alin M., Andersson T., Bredberg E., Rohss

K. Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects // Eur. J. Clin. Pharmacol. - 2000. - Vol. 56. - P. 665-670.

Hasselgren G, Lind T, Lundell L, et al. Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Scand J Gastroenterol. 1997;32:328-332.

Hasselgren G., Rohss K., Hedenstrom H. Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of GERB. Digest. Diseases And Sciences, Vol. 47, No. 5, 2002.

Hasslegren G., Hassan-Alin M., Andersson T. et al. Pharmacokinetics of esomeprazole are unaltered in the elderly // Gut. - 2000. - Vol. 47 (Suppl. III).-A62.

Johnson D.A., Benjamin S.B., Vakil N.B. et al. Es-omeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: A randomized double-blind, placebo-controlled study of efficacy and safety // Am. J. Gastroenterol. - 2001. - Vol. 96. - P. 27-34.

Мы благодарны автору и издательствам, которые не противодействует, а способствует образованию медицинских работников.
В случае нарушения авторских прав, пожалуйста, напиши нам и материалы будут незамедлительно удалены!